Dova Pharma Reports Second Quarter 2017 Operating and Financial Results
DURHAM, N.C., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today reported its operating and financial results for the quarter ended June 30, 2017.
Second Quarter and Recent Highlights
Successfully completed its initial public offering (IPO) of 5,077,250 shares at a price to the public of $17.00 per share, including the exercise in full of the underwriters’ option to purchase up to 662,250 additional shares, generating net proceeds of approximately $78.8 million, after deducting underwriting discounts and other offering expenses
Second Quarter and Recent Highlights
Successfully completed its initial public offering (IPO) of 5,077,250 shares at a price to the public of $17.00 per share, including the exercise in full of the underwriters’ option to purchase up to 662,250 additional shares, generating net proceeds of approximately $78.8 million, after deducting underwriting discounts and other offering expenses